Legacy Wealth Asset Management, LLC Genmab A/S Transaction History
Legacy Wealth Asset Management, LLC
- $324 Million
- Q4 2024
A detailed history of Legacy Wealth Asset Management, LLC transactions in Genmab A/S stock. As of the latest transaction made, Legacy Wealth Asset Management, LLC holds 36,121 shares of GMAB stock, worth $675,101. This represents 0.23% of its overall portfolio holdings.
Number of Shares
36,121
Previous 44,979
19.69%
Holding current value
$675,101
Previous $1.1 Million
31.3%
% of portfolio
0.23%
Previous 0.33%
Shares
10 transactions
Others Institutions Holding GMAB
# of Institutions
233Shares Held
52.2MCall Options Held
10.2KPut Options Held
25.5K-
Alliancebernstein L.P. New York, NY15.1MShares$283 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$95 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA4.42MShares$82.6 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.07MShares$57.3 Million0.44% of portfolio
-
Wellington Management Group LLP Boston, MA2.31MShares$43.1 Million0.01% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $12.3B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...